Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Injectable drugs remain the standard due to their proven efficacy and existing patient familiarity in both diabetes and obesity management
Safety Considerations and Provider Guidance for GLP-1 Treatment GLP-1 medications carry documented side effects including nausea, vomiting, pancreatitis risk, and thyroid concerns
Side effects Since GLP-1 receptor agonists affect the function of the digestive system, its probably not surprising that the most common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort
In terms of patient type, chronic obesity segment to command 54.0% share in the glp-1 obesity home delivery injectables market in 2026
Michailidis et al., 2022)
US$ 27.69
US$ 24.21
US$ 20.14
US$ 28.66
US$ 22.30
US$ 24.96
US$ 26.54
